Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of d-Ala₁-peptide T-amide for HIV-1-associated cognitive-motor impairment

References

• Antinori A, Giancola M L, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno C F. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS 2002; 16: 1867–1876, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Benton A L. Revised Visual Retention Test: clinical and experimental applications, 4th ed. Psychological Corp, New York 1974
   Google Scholar
• Brambilla D J, Jennings C, Morack R, Granger S, Bremer J W. Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA. J Clin Micro 2004; 42: 2819–2820, [CSA], [CROSSREF]
   Google Scholar
• Brenneman D E, Hauser J, Spong C Y, Phillips T M, Pert C B, Ruff M. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 gp120-induced neuronal death. Brain Res 1999; 838: 27–36, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Brew B J, Pemberton L, Ray J. Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?. J NeuroVirol 2004; 10(Suppl 1)38–43, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mort Weekly Rep 1992; 41(No. RR-17)1–19, [CSA]
   Google Scholar
• Escobar I, Campo M, Martin J, Fernandez-Shaw C, Pulido F, Rubio R. Factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother 2003; 37: 775–781, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Erali M, Hillyard D R. Evaluation of the ultrasensitive Roche Amplicor HIV-1 Monitor assay for quantitation of human immunodeficiency type 1 RNA. J Clin Micro 1999; 37: 792–795, [CSA]
   Google Scholar
• Gartner S. HIV infection and dementia. Science 2000; 287: 602–604, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gisslen M, Fuchs D, Svennerholm B, Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 21: 271–276, [CSA]
   Google Scholar
• Goodkin K, Shapshak P, Asthana D, Zheng W, Concha M, Wilkie F L, Molina R, Lee D, Suarez P, Symes S, Khamis I. Older age and plasma viral load in HIV-1 infection. AIDS 2004; 18(Supp1)S87–S98, [INFOTRIEVE], [CSA]
   Google Scholar
• Goodkin K, Shapshak P, Fujimura R K, Tuttle R S, Bradley W G, Yoshioka M, Nagano I, Xin K, Kumar A, Kumar M, Maher K J, Asthana D, Fletcher M A. Immune function, brain, and HIV-1 infection. Psychoneuroimmunology: stress, mental disorders and health, K Goodkin, A PH Visser. American Psychiatric Press, Washington, DC 2000; 243–316
   Google Scholar
• Grober E, Silwinski M, Korey S R. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991; 13: 933–949, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gronwall D MA. Paced Auditory Serial Addition Task: a measure of recovery from concussion. Percept Mot Skills 1977; 44: 367–373, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay C R, Sodroski J, Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385: 645–649, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heseltine P N, Goodkin K, Atkinson J H, Vitiello B, Rochon J, Heaton R K, Eaton E M, Wilkie F L, Sobel E, Brown S J, Feaster D, Schneider L, Goldschmidts W L, Stover E S. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 1998; 55: 41–51, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heyes M P, Saito K, Markey S P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. J Biochem 1992; 83: 633–635, [CSA]
   Google Scholar
• Hill J M, Mervis R F, Avidor R, Moody T W, Brenneman D E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 1993; 603: 222–233, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Hirschhorn L, Beattie A, Davidson D, Agins B (2005) The role of viral load as a measure of the quality of care for people with HIV: the expert meeting report. September, 92005, Available from: URL: http://www.hivguidelines.org/public_html/center/quality-of-care/viral-load-report.doc
   Google Scholar
• Klove H. Clinical neuropsychology. Med Clin No Amer 1963; 47: 1647–1658, [CSA]
   PubMed Web of Science ®Google Scholar
• Jackson J B, Piwowar-Manning E, Johnson-Lewis L, Bassett R, Demeter L M, Brambilla D. Comparison of versions 1.0 and 1.5 of the ultrasensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load. J Clin Micro 2004; 42: 2774–2776, [CSA], [CROSSREF]
   Google Scholar
• McCullagh P, Nelder J A. Generalized linear models. Chapman & Hall, New York 1989
   Google Scholar
• Operskalski E A, Mosley J W, Busch M P, Stram D O. Influences of age, viral load and CD4+ count on the rate of progression of HIV-1 infection to AIDS. J AIDS Hum Retrovirol 1997; 15: 243–244, [CSA]
   Google Scholar
• Parker E S, Eaton E M, Whipple S C, Heseltine P NR, Bridge T P. The University of Southern California Repeatable Episodic Memory Test. J Clin Exp Neuropsychol 1995; 17: 926–936, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pert C B, Hill J M, Ruff M R, Berman R M, Robey W G, Arthur L O, Ruscetti F W, Farrar W L. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A 1986; 83: 9254–9258, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Phipps D J, MacFadden D K. Inhibition of tumour necrosis factor-alpha explains inhibition of HIV replication by peptide T. AIDS 1996; 10: 919–920, [INFOTRIEVE], [CSA]
   Google Scholar
• Ramsdale T E, Andrews P R, Nice E C. Verification of the interaction between peptide T and CD4 using surface plasmon resonance. FEBS Lett 1993; 333: 217–222, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S P, Farber E M, Raychaudhuri S K. Immunomodulatory effects of peptide T in Th1/Th2 cytokines. Int J Immunopharmacol 1999; 21: 609–615, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S K, Raychaudhuri S P, Farber E M. Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasis. Int J Immunopharmacol 1998; 20: 661–667, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Redwine L S, Pert C B, Rone J D, Nixon R, Vance M, Sandler B, Lumpkin M D, Dieter D J, Ruff M R. Peptide T blocks gp120/CCR5 chemokine receptor-mediated chemotaxis. Clin Immunol 1999; 93: 124–131, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Reitan R M, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: theory and clinical interpretation. Neuropsychology Press, Tucson 1985
   Google Scholar
• Ruff M R, Melendez-Guerrero L M, Yang Q E, Ho W Z, Mikovits J W, Pert C B, Ruscetti F A. Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5). Antiviral Res 2001; 52: 63–75, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ruff M R, Polianova M, Yang Q E, Leoung G S, Ruscetti F W, Pert C B. Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors. Curr HIV Res 2003; 1: 51–67, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Saag M S, Holodniy M, Kuritzkes D R, O'Brien W A, Coombs R, Poscher M E, Jacobsen D M, Shaw G M, Richman D D, Volberding P A. HIV viral load markers in clinical practice. Nature Med 1996; 2: 625–629, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sacktor N, Tarwater P M, Skolasky R L, McArthur J C, Selnes O A, Becker J, Cohen B, Miller E N. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 2001; 57: 542–544, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Shapshak P, Duncan R, Minagar A, Rodriguez de la Vega P, Stewart R V, Goodkin K. Elevated expression of IFN-gamma in the HIV-1 infected brain. Front Biosci 2004; 9: 1073–1081, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Singer E, Aronow H A, Lee S-Y, Hinkin C H, Lazarus T. Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). J Clin Micro 2002; 40: 3863–3864, [CSA], [CROSSREF]
   Google Scholar
• Sodroski J, Kowalski M, Dorfman T, Basiripour L, Rosen C, Haseltine W. HIV envelope-CD4 interaction not inhibited by synthetic octapeptides. Lancet 1987; 1: 1428–1429, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Sternberg S. High speed scanning in human memory. Science 1966; 153: 652–654, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stroop J. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643–662, [CSA], [CROSSREF]
   Google Scholar
• Vandamme A-M, Van Dooren S, Kok W, Goubau P, Fransen K, Kievits T, Schmit J-C, De Clercq E, Desmyter J. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J Virol Methods 1995; 52: 121–132, [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Walczak M, Imielska D, Mackiewicz Z, Kupryszewski G, Dzierzanowska-Madalinska D, Madalinski K. The influence of D-Ala1-peptide T amide, an analogue of HIV glycoprotein 120 fragment, on the CD4–anti CD4 lymphocyte interaction. Arch Immunol Ther Exp 1991; 39: 27–31, [CSA]
   Google Scholar
• Wilkie F. Computer tests for the measurement of speed of information processing. University of Miami School of Medicine, Miami 1988
   Google Scholar
• Wilkie F L, Eisdorfer C, Morgan R, Loewenstein D A, Szapocznik J. Cognition in early human immunodeficiency virus infection. Arch Neurol 1990; 47: 433–440, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar